Prkca Protein (Protein Kinase C Alpha) plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Prkca Protein (Protein Kinase C Alpha) is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
{{Infobox protein}}
PRKCA (Protein Kinase C Alpha) is a member of the protein kinase C (PKC) family of serine/threonine kinases. It is a conventional PKC isoform requiring calcium, phosphatidylserine, and diacylglycerol (DAG) for activation.
| Attribute |
Value |
| Protein Name |
Protein Kinase C Alpha |
| Gene Symbol |
PRKCA |
| UniProt ID |
P17252 |
| Molecular Weight |
~77 kDa |
| Protein Family |
PKC family (conventional/classical) |
| Subcellular Localization |
Cytoplasm, plasma membrane, nucleus |
| Tissue Expression |
Broad (brain, heart, lung, liver, kidney) |
PRKCA contains multiple functional domains:
- N-terminal regulatory domain: Contains the C1 domain (binds DAG/phorbol esters) and C2 domain (binds calcium/phosphatidylserine)
- C-terminal catalytic domain: Contains the kinase domain with ATP-binding site
Multiple isoforms exist due to alternative splicing, with the full-length isoform being the most studied in neuronal systems.
- Signal transduction: Mediates responses to extracellular signals via G-protein-coupled receptors and receptor tyrosine kinases
- Synaptic plasticity: Critical for learning and memory processes; regulates AMPA receptor trafficking
- Cell proliferation: Controls cell cycle progression
- Apoptosis regulation: Can promote or inhibit apoptosis depending on context
- Gene transcription: Modulates transcription factor activity (NF-κB, CREB)
- Cytoskeletal dynamics: Regulates actin polymerization and cell morphology
- Long-term potentiation (LTP) and long-term depression (LTD)
- Dendritic spine formation and maintenance
- Neurotransmitter release
- Neuronal differentiation during development
PRKCA is implicated in Alzheimer's disease pathogenesis through multiple mechanisms:
- APP processing: PKC regulates α-secretase activity, influencing amyloid precursor protein (APP) processing toward the non-amyloidogenic pathway
- Tau phosphorylation: PKC can phosphorylate tau at multiple sites
- Synaptic dysfunction: Altered PKC signaling contributes to synaptic loss
- Therapeutic target: PKC modulators have been investigated as potential AD therapeutics
- Regulates dopamine release and signaling
- Involved in α-synuclein phosphorylation
- May affect mitochondrial function
- Stroke: Mediates ischemic injury and protective preconditioning
- Epilepsy: Altered PKC expression in seizure disorders
- Addiction: Mediates dopaminergic signaling in reward pathways
PKC modulators have been investigated for neurodegenerative diseases:
- PKC inhibitors: Could reduce amyloidogenic processing but have side effects
- PKC activators: May promote neuroprotection but need tissue-specific targeting
- Phosphorylation state modulators: Target specific downstream effectors
PRKCA interacts with:
- Other PKC isoforms (PRKCB, PRKCG)
- PDK1 (phosphoinositide-dependent protein kinase-1)
- AKT/PKB
- MAPK/ERK pathway components
- Synaptic proteins (PSD-95, NMDA receptors, AMPA receptors)
Prkca Protein (Protein Kinase C Alpha) plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
The study of Prkca Protein (Protein Kinase C Alpha) has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Protein kinase C in Alzheimer's disease: potential for targeted therapy - DOI:10.1016/S0197-4580(0200067-0
- PKC and synaptic plasticity in Alzheimer's disease - DOI:10.1016/j.neurobiolaging.2007.10.016
- Protein kinase C alpha and Alzheimer's disease - DOI:10.1016/j.neurobiolaging.2004.11.009
- Role of PKC in neuronal survival and death - DOI:10.1016/S0166-2236(0300151-6
- PKC in learning and memory - DOI:10.1016/S0166-2236(0300042-5
- Protein kinase C isozymes: regulation and function - DOI:10.1111/j.1742-4658.2010.07665.x
- Tau phosphorylation by protein kinase C - DOI:10.1042/0264-6021:3530313
- PKC and dopamine signaling in Parkinson's disease - DOI:10.1016/j.neuropharm.2020.107999